| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |